Our investors
NutriLeads is a clinical stage Health Ingredient company developing natural crop-derived food ingredients that enhance physiological processes in the human body as well as modulate the gut microbiome to deliver clinically proven health benefits.
We are backed by the following investors:
Additional funding
Privately held, we have also received non-dilutive funding from various regional, national and European grants, including FND agro and food, Eurostars, EFRO and SMEi from the H2020 program.
2018
NutriLeads has been awarded an “Innovatiekrediet” (government backed loan specifically for innovations) by RVO for its technical development project: “Development of Xtramune™ for application in functional foods”.
2018
NutriLeads’ NUTRI-NEED project received a €2.5 million funding under the European Innovation Council (EIC) SME Instrument (phase 2). The aim of the 2-year project is to prepare NutriLeads’ health promoting food ingredient Xtramune™ for commercialisation.
2017
NutriLeads, together with NIZO food research and Friesland Campina, was awarded a €3.7 million EFRO project to develop new food ingredients that will support resistance to infections, as well as affordable and predicative research models in humans.
2017
NutriLeads was awarded a grant “groeiversneller” from OOST NL.
2016
NutriLeads won a Eurostars grant for project NIMF to support the development of its lead ingredient Xtramune™ for application in medical foods.
2016
NutriLeads received an ‘Innovation voucher’ of the European Regional Development Fund.
2013
NutriLeads, together with NIZO food research, received an FND grant from the top sector AgriFoods.
© NutriLeads
Bronland 12-N
6708 WH Wageningen
The Netherlands
